Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer

Accumulating evidence indicates that long non-coding RNAs (lncRNAs) play important roles in tumorigenesis and progression. We aimed to identify a panel of lncRNAs for the diagnosis and recurrence prediction in bladder cancer (BC). The expression of 13 candidate lncRNAs was investigated in 80 BC and matched adjacent normal tissues via quantitative real-time PCR. The differentially expressed lncRNAs were then analyzed in 240 serum samples (training set) and three lncRNAs (MEG3, SNHG16 and MALAT1) showed differential expression. A logistic regression model was constructed using the training set and validated in an independent cohort of 200 serum samples (validation set). The AUC of the three-lncRNA panel was 0.865 for the training and 0.828 for the validation set. The diagnostic performance of the lncRNA panel for Ta, T1, and T2–T4 were 0.778, 0.805, and 0.880, which were significantly higher than those of urine cytology (0.548, 0.604, and 0.682, respectively). Moreover, we determined that low expression of MEG3 was associated with poor recurrence-free survival by Kaplan-Meier analysis (p = 0.028), univariate Cox analysis (p = 0.033) and multivariate Cox analysis (p = 0.046). In conclusion, our results identified a three-lncRNA panel for BC diagnosis and a recurrence-independent prognostic factor, MEG3.

[1]  Y. Lo,et al.  Stability of endogenous and added RNA in blood specimens, serum, and plasma. , 2002, Clinical chemistry.

[2]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[3]  Yu Fan,et al.  TGF-β–Induced Upregulation of malat1 Promotes Bladder Cancer Metastasis by Associating with suz12 , 2014, Clinical Cancer Research.

[4]  Yiran Huang,et al.  Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. , 2012, Molecular bioSystems.

[5]  Jun-Tao Jiang,et al.  Downregulation of GAS5 Promotes Bladder Cancer Cell Proliferation, Partly by Regulating CDK6 , 2013, PloS one.

[6]  U. Reinhold,et al.  Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. , 2001, Clinical chemistry.

[7]  Qing-quan Wu,et al.  Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma , 2015, Molecular Cancer.

[8]  J. Hou,et al.  Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. , 2015, International journal of clinical and experimental pathology.

[9]  Dake Chen,et al.  Long noncoding RNA GHET1 promotes the development of bladder cancer. , 2014, International journal of clinical and experimental pathology.

[10]  E. Kroh,et al.  Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.

[11]  S. Ni,et al.  Circulating CUDR, LSINCT‐5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls , 2015, International journal of cancer.

[12]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[13]  Hongtu Zheng,et al.  High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. , 2014, International journal of clinical and experimental pathology.

[14]  R. Kong,et al.  Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer , 2015, Tumor Biology.

[15]  H. Ozen.  Bladder cancer. , 1998, Current opinion in oncology.

[16]  Liping Su,et al.  MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  Zhenhua Li,et al.  ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival. , 2011, Urology.

[18]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[19]  A. Belldegrun,et al.  Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma. , 2001, Reviews in urology.

[20]  Qingqing Cai,et al.  linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer. , 2013, Biochimica et biophysica acta.

[21]  P. Wei,et al.  Down‐regulation of ncRAN, a long non‐coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients , 2015, Molecular carcinogenesis.

[22]  Zhiming Cai,et al.  Long intergenic non‐coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder , 2013, Journal of surgical oncology.

[23]  Guoxin Zhang,et al.  Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer , 2015, Scientific Reports.

[24]  W. Schulz,et al.  Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma , 2014, Clinical Epigenetics.

[25]  Y. Shao,et al.  Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer , 2015, Tumor Biology.

[26]  Beicheng Sun,et al.  The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma , 2016, Molecular carcinogenesis.

[27]  S. Verjovski-Almeida,et al.  Perspectives of Long Non-Coding RNAs in Cancer Diagnostics , 2012, Front. Gene..

[28]  Yiran Huang,et al.  Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. , 2013, Molecular bioSystems.

[29]  Z. Cai,et al.  Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer , 2015, Tumor Biology.

[30]  Takahiro Ochiya,et al.  Secretory microRNAs as a versatile communication tool , 2010, Communicative & integrative biology.